en.Wedoany.com Reported - The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to the VascularAssist Occlusion Triage (VAOT) software developed by GuideAI Health. This CT-based AI tool may help clinicians more promptly detect and triage patients with peripheral artery disease (PAD).

GuideAI Health stated that the VascularAssist Occlusion Triage software can flag cases potentially involving vascular occlusion and prioritize their review within the radiology workflow.

According to the company, in clinical performance testing, the VascularAssist Occlusion Triage software achieved 95% patient-level sensitivity in 2D CT analysis and 94% sensitivity in 3D CT evaluation.

Dr. Raj Shah, MD, MBA, CEO of GuideAI Health, noted that peripheral vascular disease is often missed or detected late, with serious consequences. VAOT brings AI-driven triage directly into the radiology workflow, helping clinicians identify vascular disease earlier and enabling patients to receive appropriate care more quickly. This clearance is the first step in the company's broader vision to set a new standard for AI-driven vascular care.

This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com